Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-22-032105

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 1.03B sh
Current Liabilities Q3 2022 · Sep 30, 2022 $8.71M
Current Liabilities Q3 2022 · Dec 31, 2021 $8.16M
Total Liabilities Q3 2022 · Sep 30, 2022 $8.78M
Total Liabilities Q3 2022 · Dec 31, 2021 $8.32M
Current Assets Q3 2022 · Sep 30, 2022 $4.43M
Current Assets Q3 2022 · Dec 31, 2021 $2.37M
Total Assets Q3 2022 · Sep 30, 2022 $4.99M
Total Assets Q3 2022 · Dec 31, 2021 $3.02M
Capex Q3 2022 · Sep 30, 2021 $79.92K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$1.41M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$5.9M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$5.02M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$6.57M
Eps Basic Q3 2022 · Sep 30, 2021 $0.00
Eps Basic Q3 2022 · Sep 30, 2021 −$0.01
Sga Expense Q3 2022 · Sep 30, 2021 $637.61K
Sga Expense Q3 2022 · Sep 30, 2021 $1.31M
Rd Expense Q3 2022 · Sep 30, 2021 $39.25K
Rd Expense Q3 2022 · Sep 30, 2021 $171.75K
Net Income Q3 2022 · Sep 30, 2021 −$3.19M
Net Income Q3 2022 · Sep 30, 2021 −$6.88M
Operating Income Q3 2022 · Sep 30, 2021 −$872.54K
Operating Income Q3 2022 · Sep 30, 2021 −$2.24M